DLA Piper advises BTG in acquisition of Novate Medical

DLA Piper represented BTG plc, a global specialist healthcare company, in its acquisition of Novate Medical Ltd., a medical device company focused on the prevention of pulmonary embolism in patients at high risk of blood clots.

BTG plans to launch Sentry, a device developed by Novate that is designed to prevent blood clots in the leg from traveling to the lungs in patients at risk of pulmonary embolism, in the second half of its current fiscal year.

Kevin Grant (Short Hills), Andrew Phillips and Yunus Maka, and included associates James Petts and Laura Evans (all of Manchester, UK).